FDA
approval
· 2022-02-17
FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)
Summary
FDA approved a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, expanding the approval through a supplemental su…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)